Signature Estate & Investment Advisors LLC Sells 1,267 Shares of UnitedHealth Group Inc (NYSE:UNH)

Signature Estate & Investment Advisors LLC cut its stake in UnitedHealth Group Inc (NYSE:UNH) by 34.1% in the second quarter, Holdings Channel reports. The institutional investor owned 2,453 shares of the healthcare conglomerate’s stock after selling 1,267 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in UnitedHealth Group were worth $598,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Eastern Bank lifted its position in shares of UnitedHealth Group by 2.0% during the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after purchasing an additional 1,375 shares during the last quarter. Enterprise Bank & Trust Co bought a new stake in shares of UnitedHealth Group in the first quarter valued at about $3,785,000. Private Advisors LLC raised its holdings in shares of UnitedHealth Group by 57.9% in the first quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock valued at $1,607,000 after acquiring an additional 2,385 shares in the last quarter. Capital Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 26.2% in the second quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after acquiring an additional 1,323 shares in the last quarter. Finally, Calton & Associates Inc. raised its holdings in shares of UnitedHealth Group by 22.7% in the second quarter. Calton & Associates Inc. now owns 2,074 shares of the healthcare conglomerate’s stock valued at $506,000 after acquiring an additional 384 shares in the last quarter. Institutional investors own 85.65% of the company’s stock.

In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 29th. The stock was sold at an average price of $241.99, for a total value of $2,419,900.00. Following the transaction, the director now owns 187,663 shares in the company, valued at $45,412,569.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the transaction, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. Insiders sold 37,000 shares of company stock worth $9,195,620 in the last quarter. 0.87% of the stock is owned by insiders.

Several analysts recently weighed in on the company. Morgan Stanley lifted their price objective on UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a report on Friday, July 12th. Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. ValuEngine downgraded UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, April 18th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $295.06.

UNH traded up $1.95 on Friday, hitting $246.20. The company had a trading volume of 1,152,780 shares, compared to its average volume of 3,495,793. The stock has a fifty day moving average price of $251.29 and a 200-day moving average price of $247.72. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67. The stock has a market capitalization of $233.18 billion, a price-to-earnings ratio of 19.11, a P/E/G ratio of 1.33 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. During the same quarter in the previous year, the firm earned $3.14 earnings per share. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $1.08 dividend. The ex-dividend date of this dividend is Friday, September 13th. This represents a $4.32 annualized dividend and a yield of 1.75%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: Understanding Market Liquidity

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.